Other
Lidocaine
0
Pipeline Programs↗
11
Active Trials↗
2
Companies Involved↗
Lidocaine is an early-stage landscape with 0 programs across 2 companies. The most active players are Scilex Pharmaceuticals, Inc., ZARS Pharma Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
140
clinical trials
Completed93 · 66%
Unknown status17 · 12%
Terminated10 · 7%
Withdrawn8 · 6%
Not yet recruiting5 · 4%
Recruiting4 · 3%
Other3 · 2%
Clinical Trials
Trial Activity
140 trials
Lidocaine Spray Use on Patients Comfort in Undergoing Bladder Catheterization
Recruiting·—·N/A·NCT06585748·100 enrolled
Comparison Between Effect of Systemic Fentanyl Infusion and Fentanyl Added as An Adjuvant to Lidocaine in Bier Block For Controlling Pain in Patients Undergoing Hand Surgeries
Not yet recruiting·—·Phase 4·NCT06696586·84 enrolled
Page 1 of 10
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)